Resurrect Bio

📍 London, United Kingdom🗓 Founded 2022👥 15 employees💰 Last funded Feb 2026
Biotechnology Research🌐 resurrect.bio
Website LinkedIn
Resurrect Bio is a VC-backed plant biotech start-up, discovering how to make crops resistant to disease using gene editing. We fix the immune system of crop species. We have a unique pipeline and platform for discovering resistance genes in crops which have been defeated by pathogens and pests. We then resurrect (restore) those resistance genes to make the crop resistant again, without introducing any new DNA to the crop. We’re focussed on delivering for the world’s farmers a better way to protect their plants, using the crops own immune system instead of spraying chemicals. This will enable them to increase food production, reduce land for agriculture and help mitigate climate change.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
United States
1
Frequently asked questions
Who invested in Resurrect Bio?
Resurrect Bio has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Resurrect Bio last raise funding?
The most recent investment in Resurrect Bio recorded on gritt.io was in February 2026.
When was Resurrect Bio founded?
Resurrect Bio was founded in 2022.
What industry is Resurrect Bio in?
Resurrect Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Resurrect Bio based?
Resurrect Bio is headquartered in London, United Kingdom.